Precarious Draft Brexit Agreement: How It Could Impact The Medtech Sector
Executive Summary
The UK does not know which direction its future will take, with respect to its current leadership and its relationship with the EU, from one hour to the next. But if the EU/UK Brexit Draft Agreement is accepted, there will be some short-term relief for the medtech sector.
You may also be interested in...
MedTech Europe One Of 15 Orgs Telling Brexit Negotiators To Include Specific Health Measures
Health organizations are up in arms over the lack of consideration of health and patients in the latest EU Brexit texts. They have written to the European Commission and may release an public statement.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.